However, the interplay between RIP3 and Nrf2 signaling pathways in the context of AKI remains unclear, and whether Tan IIA exerts its protective effects through modulating RIP3 activity has yet to be elucidated. The gene discussed is RIPK3; the disease is acute kidney injury.